Childrens Medical Center Corporation;Children's Medical Center Corporation
发明人:
WILLIAMS, David A.,DE VITA, Serena
申请号：
EP16783626
公开号：
EP3286184A4
申请日:
2016.04.15
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
This disclosure relates to compositions including certain compounds identified by a quantitative, high throughput assay to be effective in the treatment of a Rac-GTPase mediated disorder (e.g., acute lymphoblastic or chronic myelogenous leukemia), as well as methods for the manufacture of and the use of these compounds for treating a Rac-GTPase mediated disorder.
